Getting the best IP protection for your Biotech/Pharma Clients’ Inventions

Lorem Ipsum Dolor

Information

Published Date

27/06/2024

Authors

Alexander Agudelo,Daniela Kinkeldey,Sharon Crane,Martín Ré

Recording

View

Access Code

Mu2uf@ty

Patent applications for pharmaceutical and biotechnology inventions can be complicated and costly. Our panel will discuss best practices for meeting sufficiency of disclosure requirements in various jurisdictions in a cost-efficient manner. We will also consider whether alternative IP protection, such as trade secrets, would be of greater benefit to your client, particularly in view of the competitive landscape and recent eligibility challenges in obtaining patents, particularly around diagnostics.

 

Access code: Mu2uf@ty

Share: